Pimecrolimus

Results: 56



#Item
1MEDA Pharmaceuticals Pty Ltd  Elidel® Cream Pimecrolimus 1 % w/w Consumer Medicine Information

MEDA Pharmaceuticals Pty Ltd Elidel® Cream Pimecrolimus 1 % w/w Consumer Medicine Information

Add to Reading List

Source URL: www.meda.co.nz

Language: English - Date: 2016-03-15 20:00:13
    2New Zealand Datasheet Name of Medicine ELIDEL® Pimecrolimus 1% Cream  Presentation

    New Zealand Datasheet Name of Medicine ELIDEL® Pimecrolimus 1% Cream Presentation

    Add to Reading List

    Source URL: www.meda.co.nz

    Language: English - Date: 2016-03-15 20:00:14
      3

      PDF Document

      Add to Reading List

      Source URL: www.nottingham.ac.uk

      Language: English - Date: 2013-08-14 15:00:15
      4Journal of IMAB - Annual Proceeding (Scientific Papers) 2008, book 1  TREATMENT OF PSORIASIS VULGARIS WITH ELIDEL S. Racheva, R. Bachvarova, J. Dimitrova Department and clinic of dermatovenerology

      Journal of IMAB - Annual Proceeding (Scientific Papers) 2008, book 1 TREATMENT OF PSORIASIS VULGARIS WITH ELIDEL S. Racheva, R. Bachvarova, J. Dimitrova Department and clinic of dermatovenerology

      Add to Reading List

      Source URL: www.journal-imab-bg.org

      Language: English - Date: 2010-05-18 03:05:54
      5TOPICAL IMMUNOMODULATOR CRITERIA Pharmacology: Pimecrolimus inhibits the calcium-dependent phosphatase (calcineurin), interfering with T-cell activation and transcription of early cytokines. Thus, it decreases the synthe

      TOPICAL IMMUNOMODULATOR CRITERIA Pharmacology: Pimecrolimus inhibits the calcium-dependent phosphatase (calcineurin), interfering with T-cell activation and transcription of early cytokines. Thus, it decreases the synthe

      Add to Reading List

      Source URL: www.nhhealthyfamilies.com

      Language: English - Date: 2014-09-11 16:48:58
      6Atopic Dermatitis Personalized Management Plan Patient Name:_____________________________________________________ Date:_______________________________ Healthcare provider:________________________________________________

      Atopic Dermatitis Personalized Management Plan Patient Name:_____________________________________________________ Date:_______________________________ Healthcare provider:________________________________________________

      Add to Reading List

      Source URL: www.aaaai.org

      Language: English - Date: 2014-09-30 16:23:12
      7HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ELIDEL® safely and effectively. See full prescribing information for ELIDEL®. ELIDEL® (pimecrolimus) Cream, 1% fo

      HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ELIDEL® safely and effectively. See full prescribing information for ELIDEL®. ELIDEL® (pimecrolimus) Cream, 1% fo

      Add to Reading List

      Source URL: elidel-us.com

      Language: English - Date: 2014-06-19 10:56:32
      8Atopic dermatitis: A practice parameter update 2012

      Atopic dermatitis: A practice parameter update 2012

      Add to Reading List

      Source URL: www.aaaai.org

      Language: English - Date: 2013-02-06 16:22:16
      9NDA[removed]S-011 Page 3 Elidel® (pimecrolimus) Cream 1% FOR DERMATOLOGIC USE ONLY

      NDA[removed]S-011 Page 3 Elidel® (pimecrolimus) Cream 1% FOR DERMATOLOGIC USE ONLY

      Add to Reading List

      Source URL: www.accessdata.fda.gov

      Language: English - Date: 2009-03-31 14:55:22
      10ELIDEL® (pimecrolimus) Cream, 1%

      ELIDEL® (pimecrolimus) Cream, 1%

      Add to Reading List

      Source URL: www.fda.gov

      Language: English